Trial
NCT05120622
Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of British Columbia
Collaborators
—
Condition
Bladder Cancer
Intervention
Tremelimumab
Why stopped
Withdrawal of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-31